Anti-pathogenic and anti-biofilm effects of antimicrobials (Partially funded by NHMRC)

Novel combinations for bacterial infections

Integration of pharmacokinetic, pharmacodynamic and toxicodynamic principles to assist in antimicrobial development and clinical use, to reduce resistance development and to optimise efficacy (e.g. linezolid - NHMRC funded project)